Tempest Therapeutics, Inc.

NASDAQ:TPST

0.9411 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q32012 Q2
Revenue 00000000000000000000003.5550.0550.0810.0670.0910.0560.0840.0630.1210.1970.1890.1460.1570.0750.030.0159.735000000000
Cost of Revenue 0.1550.0880.0850.510.4970.5570.5390.4420.4140.4190.4090.4220.2170.176000000003.5480.0440.0540.1120.2180.0290.2740.2691.4331.5591.2331.1761.1580.940.1160.0350000000000
Gross Profit -0.155-0.088-0.085-0.51-0.497-0.557-0.539-0.442-0.414-0.419-0.409-0.422-0.217-0.176000000000.0070.0110.027-0.045-0.1270.027-0.19-0.206-1.312-1.362-1.044-1.03-1.001-0.865-0.086-0.029.735000000000
Gross Profit Ratio 00000000000000000000000.0020.20.333-0.672-1.3960.482-2.262-3.27-10.843-6.914-5.524-7.055-6.376-11.533-2.867-1.3331000000000
Reseach & Development Expenses 5.8374.344.1834.2214.4164.6785.7945.9735.6515.1094.7154.634.2293.5922.9974.2714.0943.0278.357.3085.9816.2047.731.682.3942.6213.564.0164.9975.7644.7094.995.9875.9554.6673.9984.0215.7477.2735.3254.5344.6527.2843.2622.5762.681.5951.351
General & Administrative Expenses 3.7453.6343.3312.3713.0542.9033.142.7983.1233.0522.6233.1062.5561.5351.3261.1631.1441.2764.4814.4434.1794.4531.4044.1762.6454.2244.8095.05610.7517.12910.94712.61211.2114.45414.57212.90913.06711.04611.0167.0745.0612.9983.7293.6633.4452.4951.5251.883
Selling & Marketing Expenses -0.155-0.088-0.085000000000000000000000000000000000000000000000
SG&A 3.593.5463.2462.3713.0542.9033.142.7983.1233.0522.6233.1062.5561.5351.3261.1631.1441.2764.4814.4434.1794.4531.4044.1762.6454.2244.8095.05610.7517.12910.94712.61211.2114.45414.57212.90913.06711.04611.0167.0745.0612.9983.7293.6633.4452.4951.5251.883
Other Expenses 00-0.6970.1790000.2130000000000000000.0532.8920.6924.030.3611.9921.4885.400000000000000000
Operating Expenses 9.4277.8867.4296.5927.477.5818.9348.7718.7748.1617.3387.7366.7855.1274.3235.4345.2384.30312.83111.75110.1610.6579.1345.8565.0396.8458.3699.07215.74812.89315.65617.60217.19720.40919.23916.90717.08816.79318.28912.3999.5957.6511.0136.9256.0215.1753.123.234
Operating Income -9.582-7.974-7.514-6.592-7.47-7.581-8.934-8.771-8.774-8.161-7.338-7.736-6.785-5.127-4.323-5.434-5.238-4.303-12.831-11.751-10.16-10.657-9.127-5.845-5.012-6.89-8.496-9.045-15.938-13.099-16.968-18.964-18.241-21.439-20.24-17.772-17.174-16.813-18.289-12.399-9.595-7.65-11.013-6.925-6.021-5.175-3.12-3.234
Operating Income Ratio 0000000000000000000000-2.567-106.273-61.877-102.836-93.363-161.518-189.738-207.921-140.231-96.264-96.513-146.842-128.917-236.96-572.467-1,120.867-1.879000000000
Total Other Income Expenses Net 0.0120.070.026-0.194-0.111-0.055-0.169-0.176-0.394-0.33-0.569-0.374-0.2730.173-3.039-0.94-5.4340.0750.1320.1190.2890.2912.7020.166-2.691-0.480.002-0.311-2.235-1.787-5.691-0.235-0.277-0.244-0.286-0.15-0.316-0.393-0.601-0.524-0.298-0.1640.0130.0340.0250.0180.0020
Income Before Tax -9.57-7.904-7.488-6.786-7.581-7.636-9.103-8.947-9.168-8.491-7.779-8.11-7.058-5.355-4.32-5.431-5.229-4.228-12.699-11.632-9.871-10.366-6.425-5.679-7.703-7.37-8.494-9.356-18.173-14.886-22.659-19.199-18.518-21.683-20.526-17.922-17.49-17.206-18.89-12.923-9.893-7.814-11-6.891-5.996-5.157-3.118-3.234
Income Before Tax Ratio 0000000000000000000000-1.807-103.255-95.099-110-93.341-167.071-216.345-236.286-187.264-97.457-97.979-148.514-130.739-238.96-583-1,147.067-1.94000000000
Income Tax Expense 00.045-0.472-0.0880.1610.3990.8930.1760.3940.330.5690.0630.0030.404-3.039-0.94-5.723-0.025-0.04-0.119-0.024-0.0242.7020.166-2.691-0.480.0340.0110.0130.009-0.0160.0920.050.0750.075-0.15-0.316-0.393-0.601-0.524-0.298-0.1640.0130.0340.0250.01800
Net Income -9.57-7.904-7.488-6.786-7.581-8.035-9.996-9.123-9.562-8.821-7.779-8.11-7.058-5.355-4.32-5.431-5.229-4.228-12.699-11.632-9.871-10.366-6.44-5.679-7.703-7.37-8.528-9.367-18.186-14.895-22.643-19.291-18.568-21.758-20.601-17.922-17.49-17.206-18.89-12.923-9.893-7.814-11-6.891-5.996-5.157-3.118-3.234
Net Income Ratio 0000000000000000000000-1.812-103.255-95.099-110-93.714-167.268-216.5-236.429-187.132-97.924-98.243-149.027-131.217-238.96-583-1,147.067-1.94000000000
EPS -0.42-0.36-0.35-0.48-0.54-0.58-0.95-0.67-0.83-1.23-1.16-1.21-7.63-0.81-4.67-0.82-0.79-4.67-13.72-13-11.03-11.59-7.2-35.7-48.43-46.42-53.71-58.99-114.73-93.97-142.85-121.7-139.09-162.99-169.91-147.82-144.69-142.34-156.27-106.91-94.54-74.67-105.11-65.85-57.3-86.95-0.42-2.09
EPS Diluted -0.42-0.36-0.35-0.48-0.54-0.58-0.95-0.67-0.83-1.23-1.16-1.21-7.63-0.81-4.67-0.82-0.79-4.67-13.72-13-11.03-11.59-7.2-35.7-48.43-46.42-53.71-58.99-114.73-93.97-142.85-121.7-139.09-162.99-169.91-147.82-144.69-142.34-156.27-106.91-94.54-74.67-105.11-65.85-57.3-86.95-0.42-2.09
EBITDA -9.427-7.886-7.429-6.592-7.226-7.292-8.454-8.357-8.592-8.05-7.339-7.566-6.695-5.046-4.236-5.35-5.229-4.209-11.519-11.983-10.311-10.741-7.041-5.552-7.527-7.04-8.155-8.996-17.683-14.425-22.066-18.621-17.955-21.179-19.988-17.584-17.307-16.979-18.702-12.809-9.811-7.748-10.938-6.822-5.943-5.11-3.12-3.234
EBITDA Ratio 0000000000000000000000-1.981-100.945-92.926-105.075-89.615-160.643-210.512-228.968-182.364-94.523-95-145.062-127.312-234.453-576.9-1,131.933-1.921000000000